CMI
AHCO icon

Clare Market Investments’s AdaptHealth AHCO Stock Holding History

Clare Market Investments’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,250
Closed -$691K – 159
2021
Q4 		$691K Buy
+28,250
New +$663K 0.19% 65

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Clare Market Investments's AHCO Position: Q1 2022 in Review

Clare Market Investments sold out of AdaptHealth (AHCO) in Q1 2022, closing a stake of 28,250 shares — an estimated $691K sold.

Clare Market Investments first reported a position in AHCO in Q4 2021 and held it in 1 quarter. The position peaked at $691K in Q4 2021. 154 funds tracked by Wall St. Rank hold AHCO as of Q1 2022.

  • Clare Market Investments reported no remaining AdaptHealth position as of Q1 2022 after selling out during the quarter.
  • Clare Market Investments sold 28,250 AdaptHealth shares in Q1 2022, an estimated $691K.
  • Clare Market Investments first reported a position in AdaptHealth in Q4 2021 and held it in 1 quarter.
  • Clare Market Investments's AdaptHealth position peaked at $691K in Q4 2021.
  • 154 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2022.

Based on Clare Market Investments's 13F filing for Q1 2022, filed 20 Feb 2025.